In recent years, Elon Musk has undergone a striking shift in political ideology, moving from a centrist, at times liberal-leaning stance to a firm alignment with the right wing. Once a supporter of Democratic candidates such as Barack Obama and Joe Biden, Musk has not only endorsed Donald Trump but has also become one of his most prominent financial backers. His newfound position within the federal government as the head of the Department of Government Efficiency (DOGE) raises serious legal and ethical concerns, particularly regarding the lack of congressional approval for his appointment and potential conflicts of interest due to his extensive business holdings. Moreover, Musk’s aggressive reduction of federal employees has far-reaching economic, cultural, and societal consequences.
Elon Musk’s Political Transformation
Elon Musk’s political stance has shifted dramatically over the past decade. Once a proponent of moderate policies and a donor to both major U.S. political parties, Musk has become increasingly vocal in his support for right-wing ideologies. This transformation became particularly evident in 2024 when he endorsed Trump following an assassination attempt on the former president. Musk contributed over $277 million to Trump’s campaign, making him the largest individual donor (The Times, 2025). His rhetoric on social media has also increasingly aligned with conservative and libertarian positions, particularly concerning government intervention, corporate regulation, and cultural issues such as diversity, equity, and inclusion (DEI) initiatives (The Verge, 2025).
Musk’s political realignment has not only influenced his personal engagements but has also translated into real-world policy decisions through his newly acquired governmental power.
Legal and Ethical Concerns Regarding Musk’s Appointment to DOGE
One of the most pressing concerns about Musk’s role in the Department of Government Efficiency (DOGE) is the manner in which he was appointed. Traditionally, high-level federal positions require Senate confirmation to ensure accountability and prevent undue influence from any single individual. However, Musk’s appointment by executive order bypassed this process, leading to widespread criticism and legal challenges (AP News, 2025). This move has sparked debates regarding the constitutionality of his role and whether it violates the Appointments Clause, which mandates that key federal officials be subject to legislative oversight.
Additionally, Musk’s continued involvement in his private enterprises—including Tesla, SpaceX, and X (formerly Twitter)—raises significant ethical concerns. As the head of DOGE, Musk has access to sensitive government contracts, budget allocations, and policy decisions that could directly benefit his companies. His decision to cut over $370 million in DEI grants from the Department of Education has been criticized as not only politically motivated but also as a move that could disproportionately harm marginalized communities (The Guardian, 2025). This consolidation of power, both economic and political, mirrors historical patterns of oligarchy, raising concerns about the erosion of democratic checks and balances (The Atlantic, 2025).
The Societal Impact of Musk’s Federal Employee Reductions
Musk’s leadership of DOGE has resulted in sweeping reductions of federal employees, with over 100,000 government workers losing their jobs in the first months of his tenure (Politico, 2025). While proponents argue that these cuts are necessary to reduce government spending, the economic, cultural, and societal consequences have been severe.
Economic Effects
The elimination of federal jobs has had a ripple effect on local economies, particularly in regions heavily reliant on government employment. Cities like Washington, D.C., and Arlington, Virginia, have seen declining consumer spending, rising unemployment, and weakened housing markets (AP News, 2025). The reduction in public sector jobs also exacerbates wealth inequality, as private sector positions with comparable benefits and job security are scarce.
Cultural Consequences
Beyond economic impacts, Musk’s policy shifts have targeted federal initiatives focused on diversity and inclusion. His administration’s removal of DEI funding has led to the cancellation of numerous cultural and educational programs aimed at supporting historically underrepresented groups (The Verge, 2025). The cultural message sent by these actions suggests a governmental de-prioritization of social justice efforts, aligning with broader right-wing political strategies to curtail progressive policies.
Societal Ramifications
On a broader societal level, the rapid dismantling of federal infrastructure has created instability. Essential services such as public health programs, environmental protections, and labor rights enforcement have suffered due to staffing shortages. Furthermore, Musk’s rhetoric on government inefficiency has fueled public distrust in federal institutions, deepening ideological divides and eroding faith in democracy (The Atlantic, 2025).
Conclusion
Elon Musk’s transition from an independent entrepreneur to a major political player has had profound implications. His unchecked power within DOGE, combined with significant ethical conflicts of interest, challenges the foundational principles of democratic governance. The extensive reduction of federal employees under his leadership has exacerbated economic disparity, undermined cultural inclusivity, and destabilized essential government functions. As legal challenges against his appointment and policies continue to unfold, the broader question remains: How much unchecked influence should one billionaire wield over the government and society at large?
References
AP News. (2025). “More than a dozen state attorneys general challenge Musk and DOGE’s authority.” Retrieved from https://apnews.com/article/fbb9695bcffaa96470752d56da20da57
Politico. (2025). “Elon Musk’s government job cuts spark economic downturn in key regions.” Retrieved from https://www.politico.com/news/2025/02/17/musk-government-job-cuts-economy-00204579
The Atlantic. (2025). “The Other Fear of the Founders: Oligarchy in America.” Retrieved from https://www.theatlantic.com/ideas/archive/2025/02/founders-fear-of-oligarchy/681650
The Guardian. (2025). “Trump’s policies and Musk’s federal cuts: A coordinated effort?” Retrieved from https://www.theguardian.com/us-news/2025/feb/16/trump-anti-worker-actions-unions
The Times. (2025). “OpenAI rejects $97bn offer from Elon Musk.” Retrieved from https://www.thetimes.co.uk/article/openai-rejects-97bn-offer-from-musk-zqm9zv7zv
The Verge. (2025). “The war on DEI is a smoke screen.” Retrieved from https://www.theverge.com/politics/613660/war-on-dei-smoke-screen-civil-rights-racism-eugenics
OPM Ends Gender-Affirming Care in 2026
By Katherine Walter
On August 25, 2025
In LGBTQ+ rights
To understand the gravity of this reversal, it is necessary to recall how hard-fought the gains for transgender health care under FEHB were. In 2014, OPM lifted the longstanding blanket exclusion of gender-affirming procedures, and by 2016 carriers were instructed not to categorically deny such care. This change aligned federal benefits with emerging medical consensus that gender-affirming treatments are not elective but medically necessary. The World Professional Association for Transgender Health (WPATH) and the Endocrine Society have long affirmed that access to hormone therapy and surgeries significantly reduces psychological distress, improves quality of life, and prevents serious health complications (Hembree et al., 2017; Coleman et al., 2022). For nearly a decade, transgender federal employees and retirees could rely on this coverage as a matter of equity and recognition of their humanity.
As a transgender woman who has been receiving gender-affirming health care for more than eleven years, this policy shift strikes me not just as a bureaucratic adjustment but as a direct threat to my life and well-being. Having undergone an orchiectomy, I rely on estradiol not simply as an affirming treatment, but as essential hormone replacement. Without it, my bones, cardiovascular health, cognition, and emotional stability would be at severe risk. Estradiol for me is no different than thyroid medication for someone with hypothyroidism—it is medically necessary, lifelong care. To see it lumped under a politically charged category of “optional” transition services is both scientifically inaccurate and deeply insulting.
What unsettles me most is the uncertainty this policy creates. OPM’s promise of an “exceptions process” offers little clarity. Will it protect those of us with medical histories spanning over a decade of consistent care? Or will it force us into endless appeals and denials, treating every prescription refill as a battle? This ambiguity is destabilizing, and I cannot help but feel that it is intentional—designed to make care harder to access and to discourage providers from stepping forward.
As a federal retiree, I gave years of service under the assumption that the benefits I earned would protect me equitably. Now, I feel as though my identity has made me a target within the very system I trusted. The estimated 14,000 transgender federal employees and retirees who will be affected are not faceless statistics; we are people who dedicated our careers to serving this country, only to be told that our health care needs are unworthy of recognition (Lambda Legal, 2025; them.us, 2025). The exclusion also signals a dangerous precedent: that essential medical care can be stripped away not because of evidence or cost, but because of politics.
This change must be understood in its broader social context. Over the past decade, transgender Americans have seen both progress and backlash. The Affordable Care Act’s Section 1557 extended nondiscrimination protections in health care, and the Supreme Court’s ruling in Bostock v. Clayton County (2020) affirmed that gender identity is protected under Title VII. Yet, simultaneously, states across the country have passed laws restricting access to gender-affirming care, particularly for youth, framing these measures as cultural wedge issues. The OPM directive extends that wave of exclusion into the federal system, embedding discrimination into the nation’s largest employer-based insurance program.
For me personally, this is not an abstract policy debate. It is about whether I will be able to continue accessing the medication that keeps me healthy and alive. It is about whether the years of progress we celebrated were only temporary reprieves. And it is about what message this sends to younger transgender people entering federal service today: that their health and dignity can be used as bargaining chips in political battles.
I cannot help but feel anxious about what the future holds, but I also feel resolved. This rollback will not go unchallenged. Advocacy groups such as Lambda Legal, the National Center for Transgender Equality, and others have already condemned it as unlawful and are preparing legal strategies (Lambda Legal, 2025). As a transgender woman and a retiree, I plan to add my voice to that chorus, because silence is what allows discrimination to endure. We have fought too hard, and for too long, to let the ground be taken out from under us without resistance.
References
Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L. C., Deutsch, M. B., … Winter, S. (2022). Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health, 23(sup1), S1–S259. https://doi.org/10.1080/26895269.2022.2100644
Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., … T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 102(11), 3869–3903. https://doi.org/10.1210/jc.2017-01658
Lambda Legal. (2025, August 19). Lambda Legal condemns Trump administration’s illegal exclusion of gender-affirming care from employee health benefits. Retrieved August 22, 2025, from https://lambdalegal.org/newsroom
Moss, K. (2025, August 20). Coverage for gender-affirming care will be eliminated from FEHB plans in 2026. Government Executive. Retrieved August 22, 2025, from https://www.govexec.com
Office of Personnel Management. (2025). Carrier Letter 2025-01b: Chemical and surgical sex-trait modification exclusion. Retrieved August 22, 2025, from https://opm.gov
them.us. (2025, August 20). Trump Admin to end coverage of gender-affirming care for federal workers. them. Retrieved August 22, 2025, from https://www.them